会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SULFOXIMINE AND SULFODIIMINE MATRIX METALLOPROTEINASE INHIBITORS
    • SULFOXIMINE和SULFODIIMINE MATRIX金属蛋白酶抑制剂
    • WO1995009620A1
    • 1995-04-13
    • PCT/US1994011164
    • 1994-10-03
    • FLORIDA STATE UNIVERSITY
    • FLORIDA STATE UNIVERSITYSCHWARTZ, Martin, A.WART, Hal, Van
    • A61K31/16
    • C07D233/64A61K38/00C07C381/10C07D209/18C07D263/26C07D403/12C07K5/06C07K5/06078Y10S514/824Y10S514/825Y10S514/843Y10S514/912
    • Novel sulfoximine and sulfodiimine matrix metalloproteinase inhibitors of formula (I), wherein: R is selected from the group consisting of lower-alkyl, hydroxy lower-alkyl, amino lower-alkyl, carbamoyl lower-alkyl, lower-alkyl carbonyl, lower-alkyoxyalkyl, aralkyl and heteroaralkyl; X is NH or O; R is selected from the group consisting of hydrogen, lower-alkyl and aralkyl; R is selected from the group consisting of hydrogen, lower-alkyl, amino lower-alkyl, guanyl lower-alkyl, aralkyl and heteroaralkyl; and R is selected from the group consisting of lower alkyl, aralkyl and -CH(R )-C(O)NH2, wherein R is selected from the group consisting of hydrogen, lower-alkyl, amino lower-alkyl, guanyl lower-alkyl, imidazoylalkyl, hydroxymethyl, 1-hydroxyethyl, mercapto lower-alkyl and methylthio lower-alkyl; useful for modulating physiological functions or treating diseases and disease conditions associated with matrix metalloproteinase modulation.
    • 式(I)的新型磺酰亚胺和亚磺酰亚胺基质金属蛋白酶抑制剂,其中:R 1选自低级烷基,羟基低级烷基,氨基低级烷基,氨基甲酰基低级烷基,低级烷基羰基, 低级烷氧基烷基,芳烷基和杂芳烷基; X是NH或O; R 2选自氢,低级烷基和芳烷基; R 3选自氢,低级烷基,氨基低级烷基,鸟烷基低级烷基,芳烷基和杂芳烷基; 和R 4选自低级烷基,芳烷基和-CH(R 5)-C(O)NH 2,其中R 5选自氢,低级烷基, 氨基低级烷基,鸟嘌呤低级烷基,咪唑基烷基,羟甲基,1-羟乙基,巯基低级烷基和甲硫基低级烷基; 可用于调节生理功能或治疗与基质金属蛋白酶调节相关的疾病和疾病状况。
    • 3. 发明申请
    • MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS
    • MERCAPTOSULFIDE金属蛋白酶抑制剂
    • WO1995009833A1
    • 1995-04-13
    • PCT/US1994011165
    • 1994-10-03
    • FLORIDA STATE UNIVERSITY
    • FLORIDA STATE UNIVERSITYSCHWARTZ, Martin, A.WART, Hal, Van
    • C07C233/03
    • C07D209/48C07C323/60C07D209/18C07D233/64
    • Novel mercaptosulfide matrix metalloproteinase inhibitors of formula (I), wherein n is 0 or 1; R is selected from the group consisting of hydrogen, lower alkyl, amino lower alkyl, carbamoyl lower alkyl, PhtN (lower alkyl), TsNH (lower alkyl); and R is selected from the group consisting of hydrogen, lower alkyl, amino lower alkyl, carbamoyl lower alkyl, PhtN (lower alkyl), TsNH (lower alkyl); or R and R together are -CH2-CH2-CH2-; R is selected from the group consisting of hydrogen, lower alkyl, aralkyl and heteroaralkyl; and R is selected from the group consisting of hydrogen, lower alkyl, amino lower-alkyl, guanyl lower-alkyl, imidazoylalkyl, aralkyl and 2-indolylmethyl; and R is selected from the group consisting of lower alkyl, aralkyl and -CH(R )-C(O)NH2, wherein R is selected from the group consisting of hydrogen, lower-alkyl, amino lower-alkyl, guanyl lower-alkyl, imidazoylalkyl, hydroxymethyl, 1-hydroxyethyl, mercapto lower-alkyl, and methylthio lower-alkyl; or a pharmaceutically acceptable ester, ether or salt thereof, useful for treating diseases and disease conditions associated with matrix metalloproteinase modulation.
    • 式(I)的新巯基硫化物基质金属蛋白酶抑制剂,其中n为0或1; R 1选自氢,低级烷基,氨基低级烷基,氨基甲酰基低级烷基,PhtN(低级烷基),TsNH(低级烷基); 和R 2选自氢,低级烷基,氨基低级烷基,氨基甲酰基低级烷基,PhtN(低级烷基),TsNH(低级烷基); 或R 1和R 2一起是-CH 2 -CH 2 -CH 2 - ; R 3选自氢,低级烷基,芳烷基和杂芳烷基; R 4选自氢,低级烷基,氨基低级烷基,脒基低级烷基,咪唑基烷基,芳烷基和2-吲哚基甲基; 和R 5选自低级烷基,芳烷基和-CH(R 6)-C(O)NH 2,其中R 6选自氢,低级烷基, 氨基低级烷基,鸟嘌呤低级烷基,咪唑基烷基,羟甲基,1-羟乙基,巯基低级烷基和甲硫基低级烷基; 或其药学上可接受的酯,醚或其盐,其可用于治疗与基质金属蛋白酶调节相关的疾病和疾病状况。